ADVERTISEMENT

Stock Market News Live: Nifty At 25,100, Sensex Up 200 Points; Nifty Midcap Outperforms The Benchmarks

The GIFT Nifty was trading 0.18% higher above 25,100 early Thursday. The futures contract based on the benchmark Nifty 50 rose to 25,137.5 as of 6:34 a.m.

<div class="paragraphs"><p>The GIFT Nifty was trading 0.18% higher above 25,100 early Thursday. The futures contract based on the benchmark Nifty 50 rose to 25,137.5 as of 6:34 a.m (Image source: Unsplash)</p></div>
The GIFT Nifty was trading 0.18% higher above 25,100 early Thursday. The futures contract based on the benchmark Nifty 50 rose to 25,137.5 as of 6:34 a.m (Image source: Unsplash)
ADVERTISEMENT
Good morning! Welcome to NDTV Profit's live coverage of the Indian equity markets. Here we bring you real-time updates, sharp analyst insights, top stock picks, and all the market-moving news you need. Stay tuned and stay ahead of the curve. The GIFT Nifty was trading 0.18% higher above 25,100 early Thursday. The futures contract based on the benchmark Nifty 50 rose to 25,137.5 as of 6:34 a.m., indicating a positive start for the Indian markets.
LIVE FEED
Latest First
  • Oldest First

Stock Market Live: Nifty Midcap 100 Outperforms The Benchmark

The Nifty Midcap 100 is outperforming the benchmarks as of 1:15 p.m. The gains of the Midcap index stand at 0.73%, compared to the Nifty 50, trading 0.34% higher and the Sensex that is up 200 points.

Stock Market News Live: Nifty At 25,100, Sensex Up 200 Points; Nifty Midcap Outperforms The Benchmarks

Stock Market Live: Citi On Pharma

Trump administration is not actively discussing imposing section 232 tariffs against generic pharmaceuticals

Though the move isn’t final, it is largely in-line with our stance and may help lift the tariffs-related overhang

Remain cautious on the US generics due to multiple reasons

Among the US generic heavy names, prefer Lupin on valuations


Stock Market Live: Jefferies On Pharma

Recent news provides relief to export pharma companies

Dr Reddy's, Zydus, Lupin, Cipla and Sun which derive 25-50% of their revenue from the US

Amongst generics, preferred pick is Lupin

Companies like Dr Reddy's, Zydus and Cipla may have near term earnings headwinds


Scindia Says Government Not Looking To Increase Stake In Vodafone Idea

The government will not increase its equity stake in troubled carrier Vodafone Idea Ltd., Union Telecom Minister Jyotiraditya Scindia said on Thursday.

"We are 49% equity holders in VI. At this point, and in the near future, we will not increase our stake. So that's where it will lie," Scindia told NDTV Profit at the sidelines of the India Mobile Congress 2025.

Read the full story below:

Opinion
Scindia Says Government Not Looking To Increase Stake In Vodafone Idea

Stock Market Live News: GM Breweries Share Price Surge

The shares of GM Breweries surged nearly 15% after posting strong growth in both profit and revenue in the second quarter. GM Breweries Ltd. saw a 61% rise in its year-on-year net profit for the second quarter of fiscal 2026.

Stock Market News Live: Nifty At 25,100, Sensex Up 200 Points; Nifty Midcap Outperforms The Benchmarks
Opinion
GM Breweries Share Prices Surge Nearly 14% After Revenue, Profit Jump In Q2























OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit